Antibody-drug conjugates (ADCs) represent a groundbreaking advancement in the fight against cancer. ADCs combine the precision of antibodies with the potent power of cytotoxic drugs. By carrying these potent agents directly to tumor sites, ADCs maximize treatment efficacy while minimizing harm to healthy tissues . This targeted approach holds excep